Literature DB >> 1356621

Increased inosine-5'-phosphate dehydrogenase gene expression in solid tumor tissues and tumor cell lines.

F R Collart1, C B Chubb, B L Mirkin, E Huberman.   

Abstract

Inosine-5'-phosphate (IMP) dehydrogenase, a regulatory enzyme of guanine nucleotide biosynthesis, may play a role in cell proliferation and malignancy. To assess this role we examined IMP dehydrogenase expression in a series of human solid tumor tissues and tumor cell lines in comparison with their normal counterparts. Increased IMP dehydrogenase gene expression was observed in brain tumors relative to normal brain tissue and in sarcoma cells relative to normal fibroblasts. Similarly, in several B- and T-lymphoid leukemia cell lines, elevated levels of IMP dehydrogenase mRNA and cellular enzyme were observed in comparison with the levels in peripheral blood lymphocytes. These results are consistent with an association between increased IMP dehydrogenase expression and either enhanced cell proliferation or malignant transformation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356621     DOI: 10.2172/10148922

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Transcription initiation of the yeast IMD2 gene is abolished in response to nutrient limitation through a sequence in its coding region.

Authors:  Mafalda Escobar-Henriques; Martine A Collart; Bertrand Daignan-Fornier
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

Review 2.  Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapy.

Authors:  Gerson Dierley Keppeke; S John Calise; Edward K L Chan; Luis Eduardo C Andrade
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

3.  Dynamic compartmentalization of purine nucleotide metabolic enzymes at leading edge in highly motile renal cell carcinoma.

Authors:  Kara Wolfe; Satoshi Kofuji; Hirofumi Yoshino; Mika Sasaki; Koichi Okumura; Atsuo T Sasaki
Journal:  Biochem Biophys Res Commun       Date:  2019-06-10       Impact factor: 3.575

4.  IMPDH-Based Cytoophidium Structures as Potential Theranostics in Cancer.

Authors:  Gerson Dierley Keppeke; Luis Eduardo Coelho Andrade; Denise Barcelos; Mariana Fernandes; Gilles Landman
Journal:  Mol Ther       Date:  2020-06-11       Impact factor: 11.454

5.  Inhibition of T lymphocyte activation in mice heterozygous for loss of the IMPDH II gene.

Authors:  J J Gu; S Stegmann; K Gathy; R Murray; J Laliberte; L Ayscue; B S Mitchell
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

6.  Inosine-5'-monophosphate dehydrogenase is a rate-determining factor for p53-dependent growth regulation.

Authors:  Y Liu; S A Bohn; J L Sherley
Journal:  Mol Biol Cell       Date:  1998-01       Impact factor: 4.138

Review 7.  The targets of curcumin.

Authors:  Hongyu Zhou; Christopher S Beevers; Shile Huang
Journal:  Curr Drug Targets       Date:  2011-03-01       Impact factor: 3.465

8.  Identification of IMPDH2 as a tumor-associated antigen in colorectal cancer using immunoproteomics analysis.

Authors:  Yujun He; Zhirong Mou; Wanlin Li; Baohua Liu; Tao Fu; Shong Zhao; Debing Xiang; Yuzhang Wu
Journal:  Int J Colorectal Dis       Date:  2009-07-14       Impact factor: 2.571

9.  Targeted disruption of the inosine 5'-monophosphate dehydrogenase type I gene in mice.

Authors:  Jing Jin Gu; Amy K Tolin; Jugnu Jain; Hai Huang; Lalaine Santiago; Beverly S Mitchell
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

10.  IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations.

Authors:  Sofie Haglund; Jan Taipalensuu; Curt Peterson; Sven Almer
Journal:  Br J Clin Pharmacol       Date:  2007-07-27       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.